Skip to content

Clinical trials

Completed Thyroid Cancer, Papillary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Cancer, Papillary Status: Completed Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20034
20045
20052
20064
20074
20082
20091
20103
20115
20125
20132
20144
20155
20161
20171
20183
20192
20204
20215
20225
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Massachusetts General Hospital3
Yonsei University3
Academic and Community Cancer Research United2
Chinese PLA General Hospital2
European Organisation for Research and Treatment of Cancer - EORTC2
Exelixis2
Memorial Sloan Kettering Cancer Center2
Radboud University Medical Center2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Cancer, Papillary81
Thyroid Neoplasms41
Adenocarcinoma, Follicular34
Carcinoma, Medullary17
Head and Neck Neoplasms11
Thyroid Carcinoma, Anaplastic9
Carcinoma, Non-Small-Cell Lung8
Colonic Neoplasms8
Lymphatic Metastasis7
Salivary Gland Neoplasms7

Trials

Showing 51 to 75 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.